experimental group:Rapamycin

2 trials

Sponsors

The First Medical Center of PLA General Hospital, Beijing Children’s Hospital, Capital Medical University

Conditions

Autism Spectrum DisorderBenign peripheral neuroblastic tumors (including GNBi and GN)

Early Phase 1

Study on the treatment of autism spectrum disorders in children with mTOR inhibitor rapamycin

Active, not recruitingChiCTR2000032184

The First Medical Center of PLA General HospitalAutism Spectrum Disorder

Start: 2020-06-01Updated: 2020-04-27

Prospective clinical study on the safety and efficacy of rapamycin in the treatment of unresectable or postoperative residual benign peripheral neuroblastic tumors

RecruitingChiCTR2300070701

Beijing Children’s Hospital, Capital Medical UniversityBenign peripheral neuroblastic tumors (including GNBi and GN)

Start: 2023-04-10Updated: 2023-06-04